Viz.ai
Founded Year
2016Stage
Series D - II | AliveTotal Raised
$289.25MLast Raised
$40M | 2 yrs agoRevenue
$0000Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-42 points in the past 30 days
About Viz.ai
Viz.ai operates as a company focused on the use of artificial intelligence (AI) in the healthcare sector. The company offers an AI-powered care coordination platform that leverages advanced algorithms to analyze medical imaging data, providing real-time insights and automated assessments to accelerate diagnosis and treatment. The company primarily serves the healthcare industry. It was founded in 2016 and is based in San Francisco, California.
Loading...
Viz.ai's Product Videos
ESPs containing Viz.ai
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The radiology AI — electrocardiogram (ECG) diagnostics market focuses on the development and adoption of AI-powered solutions designed to assist in the interpretation and analysis of electrocardiogram (ECG) data. ECG is a critical diagnostic tool for assessing the electrical activity of the heart, and AI applications in this market aim to improve the accuracy and efficiency of diagnosing cardiac c…
Viz.ai named as Leader among 11 other companies, including Tempus, AliveCor, and Anumana.
Viz.ai's Products & Differentiators
Viz Neuro Suite
Viz Neuro Suite encompasses AI algorithms to detect suspected stroke, aneurysms, subdural hematomas and more.
Loading...
Research containing Viz.ai
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Viz.ai in 8 CB Insights research briefs, most recently on Apr 25, 2024.
Expert Collections containing Viz.ai
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Viz.ai is included in 5 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,244 items
AI 100
200 items
Artificial Intelligence
14,767 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health 50
450 items
The most promising digital health startups transforming the healthcare industry
Digital Health
11,072 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Viz.ai Patents
Viz.ai has filed 23 patents.
The 3 most popular patent topics include:
- medical tests
- medical terminology
- emergency medicine
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/25/2022 | 8/20/2024 | Medical tests, Triage, Health informatics, Emergency medicine, Medical terminology | Grant |
Application Date | 8/25/2022 |
|---|---|
Grant Date | 8/20/2024 |
Title | |
Related Topics | Medical tests, Triage, Health informatics, Emergency medicine, Medical terminology |
Status | Grant |
Latest Viz.ai News
Sep 19, 2024
September 19, 2024 Viz.ai, an AI-driven healthcare solutions leader, has partnered with Cleerly, a company focused on revolutionizing heart disease diagnostics, to integrate Cleerly's AI-enabled cardiovascular tools into the Viz.ai One platform. This collaboration, announced on September 4, 2024, aims to streamline the detection and treatment of heart disease, the leading global cause of death. Cleerly's advanced FDA-approved software uses coronary computed tomography angiography images and AI algorithms to detect ischemia, and stenosis, and quantify plaque, facilitating early diagnosis and personalized treatment. The Viz.ai One platform, already used in over 1,600 hospitals, will now offer enhanced cardiology services, providing healthcare teams with more accurate and timely patient data. Viz.ai, which serves more than 1,700 hospitals across the U.S. and Europe, is known for using AI algorithms to expedite diagnosis and care coordination. Cleerly’s integration will help optimize care pathways by offering precision diagnostics, providing clinicians with comprehensive analyses of coronary artery disease. According to leaders from both organizations, this partnership signifies a shared commitment to expanding access to life-saving treatments and improving patient outcomes through AI-powered healthcare solutions. With this collaboration, both companies are poised to transform cardiovascular care, facilitating early detection of heart disease and enhancing clinical impact. Become a Subscriber
Viz.ai Frequently Asked Questions (FAQ)
When was Viz.ai founded?
Viz.ai was founded in 2016.
Where is Viz.ai's headquarters?
Viz.ai's headquarters is located at 1819 Polk Street 293, San Francisco.
What is Viz.ai's latest funding round?
Viz.ai's latest funding round is Series D - II.
How much did Viz.ai raise?
Viz.ai raised a total of $289.25M.
Who are the investors of Viz.ai?
Investors of Viz.ai include CIBC Innovation Banking, Kleiner Perkins, Susa Ventures, CRV, Threshold Ventures and 15 more.
Who are Viz.ai's competitors?
Competitors of Viz.ai include Subtle Medical, AIRS Medical, Quibim, Aidoc, RapidAI and 7 more.
What products does Viz.ai offer?
Viz.ai's products include Viz Neuro Suite and 4 more.
Loading...
Compare Viz.ai to Competitors
RADLogics is a healthcare software company that focuses on developing artificial intelligence (AI)-powered solutions in the medical imaging industry. The company's main offerings include machine learning image analysis solutions that aim to improve radiologists' productivity and enhance patient outcomes by reducing diagnostic turnaround time and automating detection and report generation functions. RADLogics primarily serves the healthcare industry. It was founded in 2010 and is based in New York, New York.
Aidoc focuses on clinical artificial intelligence (AI) in the healthcare domain. The company offers AI solutions that analyze and aggregate medical data to increase hospital efficiency, improve patient outcomes, and enable better decision-making by healthcare teams. It primarily caters to the healthcare industry. It was founded in 2016 and is based in Tel Aviv, Israel.
Arterys is a company that focuses on the integration of artificial intelligence and data in the medical sector, specifically in the domain of radiology. The company offers a cloud-based platform that uses AI to extract actionable insights from medical images, aiming to improve diagnostic decision making, efficiency, and productivity. Its services primarily cater to the healthcare industry. Arterys was formerly known as Morpheus Medical, Inc.. It was founded in 2011 and is based in San Francisco, California.
EnvoyAI, now part of TeraRecon, focuses on advanced visualization and artificial intelligence in the medical imaging sector. The company offers AI-powered solutions to enhance medical imaging workflows, including tools for radiology, cardiology, and neurology. These solutions aim to improve patient care by providing insights and decision support to healthcare professionals. It was founded in 2016 and is based in Durham, North Carolina.
Imagen focuses on providing technology-enabled diagnostic solutions in the healthcare sector. The company offers AI-enhanced medical interpretation and FDA-cleared diagnostic software designed to improve the accuracy and efficiency of medical imaging. Imagen primarily serves the healthcare industry, equipping primary care practices with advanced diagnostic tools and support. It was founded in 2015 and is based in New York, New York.
Mirada Medical specializes in medical imaging software within the healthcare technology sector. The company offers software applications that facilitate image analysis for cancer diagnosis and treatment, incorporating AI and automation to enhance clinician productivity and patient care. Mirada Medical's products are primarily utilized in the radiation oncology, diagnostic imaging, and interventional radiology sectors. It was founded in 2000 and is based in Oxford, England. Mirada Medical operates as a subsidiary of CTI Molecular Imaging.
Loading...